What is the recommended dose conversion when switching from metoprolol tartrate to metoprolol succinate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metoprolol Tartrate to Succinate Conversion

When converting from metoprolol tartrate to metoprolol succinate, use a 1:1 dose conversion ratio, where 100 mg of metoprolol tartrate (given twice daily) equals 100 mg of metoprolol succinate (given once daily). 1

Dosage Equivalence

  • Metoprolol tartrate is typically administered twice daily (BID), while metoprolol succinate (XL/ER) is administered once daily (QD) 1
  • A 100 mg metoprolol succinate extended-release tablet contains 95 mg of metoprolol succinate and is considered therapeutically equivalent to 100 mg of metoprolol tartrate 2
  • Common dosing ranges:
    • Metoprolol tartrate: 25-100 mg BID (total daily dose 50-200 mg) 1
    • Metoprolol succinate: 50-400 mg QD 1

Pharmacological Differences

  • Metoprolol succinate uses a controlled release/extended-release formulation designed to provide relatively constant plasma concentrations over approximately 20 hours 2
  • After ingestion, the metoprolol succinate tablet disintegrates into individual pellets with each pellet acting as a diffusion cell releasing the drug at a relatively constant rate 2
  • Both formulations produce similar hemodynamic and clinical effects despite different dosing schedules 3

Clinical Considerations for Conversion

  • When transitioning from tartrate to succinate in patients with cardiovascular conditions:

    • For patients on metoprolol tartrate 25 mg BID → convert to metoprolol succinate 50 mg QD 1
    • For patients on metoprolol tartrate 50 mg BID → convert to metoprolol succinate 100 mg QD 1
    • For patients on metoprolol tartrate 100 mg BID → convert to metoprolol succinate 200 mg QD 1
  • In post-MI or heart failure patients, a gradual transition over 2-3 days from metoprolol tartrate to succinate is recommended to ensure stable blood levels 1

Special Considerations

  • Metoprolol succinate may offer advantages over tartrate in certain clinical scenarios:

    • Better adherence with once-daily dosing 2
    • More consistent 24-hour beta-blockade with fewer peak/trough fluctuations 2, 3
    • May be preferred in heart failure patients due to more consistent hemodynamic effects 3
  • Common pitfalls to avoid:

    • Ensure patients understand the change in dosing frequency (from twice daily to once daily) to prevent medication errors 1
    • Monitor for adequate blood pressure and heart rate control during the transition period 1
    • Be aware that metoprolol succinate is sometimes available in higher single doses than tartrate (up to 400 mg) 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.